Literature DB >> 27163584

Correction: Increased Intra-Individual Variability of Cognitive Processing in Subjects at Risk Mental State and Schizophrenia Patients.

Ye Seul Shin, Sung Nyun Kim, Na Young Shin, Wi Hoon Jung, Ji-Won Hur, Min Soo Byun, Joon Hwan Jang, Suk Kyoon An, Jun Soo Kwon.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0078354.].

Entities:  

Year:  2016        PMID: 27163584      PMCID: PMC4862664          DOI: 10.1371/journal.pone.0155573

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Table 2 appears incorrectly in the published article. Please see the correct Table 2 and its caption here.
Table 2

Mean performance on the stop-signal task in normal controls, ARMS subjects and schizophrenia patients; these means were examined using ANOVAs.

Control(n = 38)ARMS(n = 27)Schizophrenia(n = 37)Statistics
FP
IIV stop19.04(17.32)38.70(28.54)36.90(24.79)7.570.001 a,b
IIV go87.79 (59.28)154.65(96.11)132.06(72.99)6.780.002 a,b
SSRT159.46(48.17)216.01(108.02)231.11(127.90)5.320.006 a,b
Go RT459.65(143.20)561.01(173.93)547.82(152.18)4.420.015 a
PSS0.51(0.09)0.55(0.16)0.54(0.16)0.650.524

Note. Data are presented as the means (SD). ARMS = at-risk mental state; IIV = intra-individual variability; SSRT = stop-signal reaction rime; Go RT = reaction time on go trials; PSS = proportion of successful stops.

a p < 0.05 for two-tailed tests.

b p < 0.01 adjusted significance for two-tailed tests with application of Bonferroni correction for multiple comparisons.

Note. Data are presented as the means (SD). ARMS = at-risk mental state; IIV = intra-individual variability; SSRT = stop-signal reaction rime; Go RT = reaction time on go trials; PSS = proportion of successful stops. a p < 0.05 for two-tailed tests. b p < 0.01 adjusted significance for two-tailed tests with application of Bonferroni correction for multiple comparisons.
  1 in total

1.  Increased intra-individual variability of cognitive processing in subjects at risk mental state and schizophrenia patients.

Authors:  Ye Seul Shin; Sung Nyun Kim; Na Young Shin; Wi Hoon Jung; Ji-Won Hur; Min Soo Byun; Joon Hwan Jang; Suk Kyoon An; Jun Soo Kwon
Journal:  PLoS One       Date:  2013-11-08       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.